Where is Immutrin's headquarters?

Immutrin is located in Cambridge, Cambridgeshire, United Kingdom.

Who invested in Immutrin?

Immutrin has 7 investors including Cambridge Innovation Capital And F-Prime.

Immutrin closed its last funding round on obfuscated from a Series A round.

Alternatives and possible competitors to Immutrin may include Eli Lilly, Alnylam Pharmaceuticals, And AstraZeneca.

Immutrin has raised obfuscated.

is actively using

technologies for its website, according to BuiltWith. These include

has

registered patent in the '

' category, according to IPqwery.

Active Tech Count

Monthly Visits

1,104

Active Technology